Other equities research analysts also recently issued reports about the company. Cantor Fitzgerald reaffirmed a buy rating and set a $80.00 price objective on shares of U.S. Physical Therapy in a report on Tuesday, January 9th. Zacks Investment Research raised U.S. Physical Therapy from a hold rating to a buy rating and set a $82.00 price objective on the stock in a report on Saturday, January 6th. Finally, Barrington Research downgraded U.S. Physical Therapy from an outperform rating to a market perform rating in a report on Friday, November 3rd. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. U.S. Physical Therapy has a consensus rating of Buy and a consensus target price of $76.00.
Shares of U.S. Physical Therapy (NYSE:USPH) opened at $78.70 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.04 and a current ratio of 2.04. The firm has a market capitalization of $990.12, a P/E ratio of 47.41, a price-to-earnings-growth ratio of 2.91 and a beta of 1.22. U.S. Physical Therapy has a 1-year low of $56.50 and a 1-year high of $79.75.
Institutional investors and hedge funds have recently made changes to their positions in the company. SG Americas Securities LLC acquired a new position in shares of U.S. Physical Therapy in the 3rd quarter worth approximately $170,000. UBS Asset Management Americas Inc. acquired a new position in shares of U.S. Physical Therapy in the 4th quarter worth approximately $206,000. Ladenburg Thalmann Financial Services Inc. boosted its holdings in shares of U.S. Physical Therapy by 59.9% in the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,770 shares of the company’s stock worth $231,000 after acquiring an additional 1,412 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in shares of U.S. Physical Therapy by 48.6% in the 4th quarter. Envestnet Asset Management Inc. now owns 3,704 shares of the company’s stock worth $267,000 after acquiring an additional 1,212 shares in the last quarter. Finally, Crossmark Global Holdings Inc. acquired a new position in shares of U.S. Physical Therapy in the 3rd quarter worth approximately $274,000. 96.19% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “Jefferies Group Reiterates $76.00 Price Target for U.S. Physical Therapy (USPH)” was originally reported by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3222446/jefferies-group-reiterates-76-00-price-target-for-u-s-physical-therapy-usph.html.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.